| |
| |
|
| Insider
Information: |
Vivo Ventures Vi Affiilates Fund, L.p. |
| Relationship: |
10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,242,878 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$51,211,565 |
|
|
| Total
Shares |
4,242,878 |
|
|
| Total
Value |
$51,211,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sagent Pharmaceuticals Inc |
SGNT |
10% Owner |
|
0 |
2016-04-21 |
25,320 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2015-04-14 |
0 |
2015-04-14 |
4,204,562 |
Premium* |
|
|
Celladon Corp |
CLDN |
10% Owner |
2016-08-18 |
0 |
2016-08-18 |
12,996 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDN |
Celladon Corp |
10% Owner |
• • • |
2016-08-18 |
4 |
B |
$16.00 |
$3,000,000 |
I/I |
187,500 |
12,996 |
1.5 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2016-04-21 |
4 |
S |
$13.55 |
$31,382 |
I/I |
(2,316) |
25,320 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2015-11-04 |
4 |
S |
$15.45 |
$8,281,463 |
I/I |
(536,017) |
25,337 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2015-11-03 |
4 |
S |
$16.32 |
$1,098,059 |
I/I |
(67,283) |
29,235 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2015-11-02 |
4 |
S |
$16.87 |
$1,577,686 |
I/I |
(93,523) |
29,725 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2015-04-14 |
4/A |
B |
$5.00 |
$5,062,500 |
I/I |
1,012,500 |
4,204,562 |
1.5 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2015-04-14 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,192,062 |
3,192,062 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2015-04-14 |
4 |
B |
$5.00 |
$5,062,500 |
I/I |
1,012,500 |
4,204,564 |
1.5 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2015-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,192,064 |
3,192,064 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2013-09-16 |
4 |
S |
$21.25 |
$13,232,375 |
I/I |
(622,700) |
30,405 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
10% Owner |
– – • |
2011-04-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,803,490 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
